Shyama Computronics and Services
3.75
+0.03(+0.81%)
Market Cap₹3.73 Cr
PE Ratio33.82
IndustryHealthcare
Company Performance:
1D+0.81%
1M-1.83%
6M+16.82%
1Y0.00%
5Y0.00%
View Company Insightsright
More news about Shyama Computronics and Services
09Apr 26
Shyama Computronics and Services Limited Submits SEBI Compliance Certificate for Q4FY26
Shyama Computronics and Services Limited filed its SEBI compliance certificate under Regulation 74(5) for Q4FY26 on 9th April, 2026. The certificate, prepared by registrar Niche Technologies Private Limited, confirms proper processing of dematerialisation requests during the quarter ended 31st March, 2026, with all security certificates being mutilated and cancelled after verification and depository names substituted in the member register.
 no imag found
10Feb 26
SHYAMA Computronics & Services Ltd. Publishes Q3FY26 Financial Results in Newspapers
SHYAMA Computronics & Services Ltd. has completed the mandatory newspaper publication of its Q3FY26 financial results in Financial Express and Pratahkal on 30th January, 2026, as required under SEBI Listing Regulations. The company reported total income of ₹9.74 lakhs and net profit after tax of ₹3.91 lakhs for the quarter ended 31st December, 2025, with earnings per share of ₹0.04.
 no imag found
25Nov 25
Shyama Computronics Appoints New Managing Director and Director Through Postal Ballot
Shyama Computronics and Services Limited has appointed Mr. Rajib Singh as Managing Director and Mr. Dipak Kumar Das as Director through a postal ballot process. The e-voting, conducted from October 26 to November 24, 2025, saw participation from 24 members representing 1,050,550 equity shares. Both appointments were approved with 85.83% votes in favor, demonstrating strong shareholder support. The transparent voting process aligns with good corporate governance practices.
 no imag found
13Nov 25
Shyama Computronics Reports Decline in Half-Year Profits for September 2025
Shyama Computronics and Services Limited released its unaudited standalone financial results for the half year ended September 30, 2025. The company's profit before tax decreased by 54.65% to Rs 7.90 lacs, down from Rs 17.42 lacs in the same period last year. However, cash and cash equivalents increased by 40.50% to Rs 1.70 lacs. The results were approved by the Board of Directors on November 12, 2025, and reviewed by statutory auditors AO Mittal Associates.
 no imag found
18Aug 25
Shyama Computronics Announces Major Leadership Overhaul and Key Appointments
Shyama Computronics and Services Limited (BSE: 531219) has announced significant leadership changes effective August 14, 2025. Mr. Rajib Singh has been appointed as the new Managing Director, replacing Mr. Samir Biswas. Mr. Dipak Kumar Das has been named the new Executive Director, succeeding Mr. Amit Paul. Both appointments are for five-year terms and subject to shareholder approval. The company has also appointed Mr. Sachin Pilania as Secretarial Auditor and Mr. Abhiset Basu as Internal Auditor. The board approved unaudited financial results for Q2 2025 and scheduled the 29th AGM for September 15, 2025, to be held via video conference.
 no imag found
14Aug 25
Shyama Computronics Announces Major Leadership Changes and Approves Q1 FY2026 Results
Shyama Computronics and Services Limited (BSE: 531219) has announced major leadership changes and approved Q1 FY2025-26 financial results. Mr. Rajib Singh and Mr. Dipak Kumar Das have been appointed as Managing Director and Executive Director respectively for five-year terms, replacing Mr. Samir Biswas and Mr. Amit Paul who have resigned. The company also appointed Mr. Sachin Pilania as Secretarial Auditor and Mr. Abhiset Basu as Internal Auditor. The Board approved unaudited Q1 results and scheduled the 29th AGM for September 15, 2025, via video conferencing.
 no imag found
1 Year Returns:0.00%
Industry Peers
Sun Pharmaceutical
1,840.00
(-1.13%)
Divis Laboratories
9,322.00
(-1.23%)
Torrent Pharmaceuticals
4,965.50
(+0.72%)
Zydus Life Science
1,119.10
(+0.12%)
Cipla
1,366.00
(-0.53%)
Laurus Labs
1,969.00
(+1.23%)
Dr Reddys Laboratories
1,165.50
(+1.97%)
Aurobindo Pharma
1,679.80
(+0.68%)
Lupin
2,095.00
(+0.83%)
Mankind Pharma
2,280.00
(+1.86%)